SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-112480
Filing Date
2021-09-02
Accepted
2021-09-02 16:09:28
Documents
1
Period of Report
2021-08-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2123911-14_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2123911-14_4seq1.xml 4 3343
  Complete submission text file 0001104659-21-112480.txt   4825
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Issuer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address
Gelone Steven P. (Reporting) CIK: 0001693064 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37558 | Film No.: 211233338